Skip to main content
. 2022 Mar 21;38(3):533–544. doi: 10.1016/j.cger.2022.03.005

Fig. 1.

Fig. 1

Physiopathologic pathways of post–COVID-19 sarcopenia. ACE, angiotensin-converting-enzyme; CMV, cytomegalovirus; CD6, cluster of differentiation 6; HTA, Hypertension.

(Adapted from Piotrowicz, K., Gąsowski, J., Michel, JP. et al. Post-COVID-19 acute sarcopenia: physiopathology and management. Aging Clin Exp Res 33, 2887–2898 (2021). https://doi.org/10.1007/s40520-021-01942-8; under Creative Commons Attribution 4.0 International License.)